These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 39289634)

  • 1. Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.
    Chen F; Weng W; Yang D; Wang X; Zhou Y
    BMC Cardiovasc Disord; 2024 Sep; 24(1):496. PubMed ID: 39289634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention.
    Wang L; Ma Y; Jin W; Zhu T; Wang J; Yu C; Zhang F; Jiang B
    BMC Cardiovasc Disord; 2022 Dec; 22(1):572. PubMed ID: 36577944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction.
    Srivaratharajah K; Coutinho T; deKemp R; Liu P; Haddad H; Stadnick E; Davies RA; Chih S; Dwivedi G; Guo A; Wells GA; Bernick J; Beanlands R; Mielniczuk LM
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
    Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting Myocardial Contrast Echocardiography for the Evaluation of Coronary Microcirculation Dysfunction in Patients With Early Coronary Artery Disease.
    Li X; He S; Zhang YS; Chen Y; He JC
    Clin Cardiol; 2016 Aug; 39(8):453-8. PubMed ID: 27163691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study.
    Li XN; Liu YT; Kang S; Qu Yang DZ; Xiao HY; Ma WK; Shen CX; Pan JW
    Cardiovasc Diabetol; 2024 Aug; 23(1):303. PubMed ID: 39152461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of modified coronary flow capacity by
    Miura S; Naya M; Kumamaru H; Ando A; Miyazaki C; Yamashita T
    J Cardiol; 2022 Feb; 79(2):247-256. PubMed ID: 34538532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction.
    Markley R; Del Buono MG; Mihalick V; Pandelidis A; Trankle C; Jordan JH; Decamp K; Winston C; Carbone S; Billingsley H; Barron A; Thomas G; Van Tassell B; Hundley WG; Kellman P; Abbate A
    Int J Cardiovasc Imaging; 2023 Apr; 39(4):811-819. PubMed ID: 36607469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
    Nakata T; Hashimoto A; Wakabayashi T; Kusuoka H; Nishimura T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1393-400. PubMed ID: 20083074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
    Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
    JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):112. PubMed ID: 34657615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Microvascular Resistance Reserve on the Outcome of Patients With STEMI.
    Tsai TY; Aldujeli A; Haq A; Knokneris A; Briedis K; Hughes D; Unikas R; Renkens M; Revaiah PC; Tobe A; Miyashita K; Sharif F; Garg S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2024 May; 17(10):1214-1227. PubMed ID: 38752970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
    Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
    Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
    Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
    Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
    J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.